Top Markets
Coin of the day
Angion Biomedica Corp. Angion Biomedica Corp.

Angion Biomedica Corp.

ANGN
Classement en actions #27858
Angion Biomedica Corp. operates as a biopharmaceutical enterprise,... Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ damage and scarring conditions. Its primary investigational compound, ANG-3070, is an orally administered tyrosine kinase receptor inhibitor currently being developed to address fibrotic ailments, particularly those impacting the kidneys and lungs. The company's product pipeline also features ANG-3777, a hepatocyte growth factor mimetic engineered to treat acute organ injuries like delayed graft function, in addition to initiatives for ROCK2 inhibitors targeting fibrotic diseases and a CYP11B2 inhibitor program. Established in 1998, Angion Biomedica Corp. maintains its headquarters in Uniondale, New York.
Prix de l'action
$1.00
Dernière synchronisation: 2023-06-01
Capitalisation boursière
$30.11M
Changement (1 jour)
2.04%
Changement (1 an)
0.00%
Pays
US
Échange Angion Biomedica Corp. (ANGN)

Catégorie

Historique du prix de l'action pour Angion Biomedica Corp. (ANGN)
Prix de clôture le plus élevé : $1.00 le 2023-06-01

Prix de clôture le plus bas : $20.49 le 2021-02-01
Historique du prix de l'action de Angion Biomedica Corp. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 18.73%
2022 -70.78%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$121.65 -14.34%
AU
$753.28 5.84%
CH